Original Research
Published on 30 Jun 2023
Cost-effectiveness analysis of trastuzumab deruxtecan in patients with HER2-low advanced breast cancer based on DESTINY-Breast04
in Health Economics
- 6,897 views
- 7 citations
Original Research
Published on 30 Jun 2023
in Health Economics
Original Research
Published on 30 Jun 2023
in Health Economics
Original Research
Published on 29 Jun 2023
in Health Economics
Original Research
Published on 27 Jun 2023
in Health Economics
Original Research
Published on 26 Jun 2023
in Health Economics
Original Research
Published on 23 Jun 2023
in Health Economics
Original Research
Published on 22 Jun 2023
in Health Economics
Original Research
Published on 22 Jun 2023
in Health Economics
Original Research
Published on 22 Jun 2023
in Health Economics
Systematic Review
Published on 21 Jun 2023
in Health Economics
Original Research
Published on 19 Jun 2023
in Health Economics
Original Research
Published on 19 Jun 2023
in Health Economics
Original Research
Published on 15 Jun 2023
in Health Economics
Original Research
Published on 15 Jun 2023
in Health Economics
Systematic Review
Published on 09 Jun 2023
in Health Economics
Original Research
Published on 08 Jun 2023
in Health Economics